Status:
UNKNOWN
Mucopexy Versus Laser Hemorrhoidoplasty for the Treatment of Hemorrhoidal Disease
Lead Sponsor:
Ris Frederic
Conditions:
Hemorrhoids
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hemorrhoidal disease is a frequent anorectal disorder and the main reason for a visit to a coloproctologist. Hemorrhoids are present in healthy individuals. However, they can become pathologic, manife...
Eligibility Criteria
Inclusion
- Informed Consent as documented by signature
- Hemorrhoidal disease grade II to III unresponsive to medical therapy
- Age ≥18
Exclusion
- Inability to follow the procedures of the study,
- Enrollment of the investigator, his/her family members, employees and other dependent persons,
- Anesthesiology contraindications to surgery,
- Emergency situation,
- Hemorrhoids associated with pregnancy,
- Oher surgical intervention performed at the same time of the hemorrhoids treatment,
- Concomitant anorectal disorders (fissure, fistula), thrombosed hemorrhoid,
- Previous pelvic radiotherapy, previous proctologic intervention during the last three months.
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04881344
Start Date
June 1 2021
End Date
December 1 2022
Last Update
May 11 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.